Chris Welch

Chris Welch is a seasoned entrepreneur and investor with extensive experience in the sports and pharmaceutical industries. As the founder of ESB Holdings, Welch has brokered notable deals in Formula One, including partnerships with Ferrari and Alfa Romeo. In addition to their role at ESB, Welch engages in business development and fundraising for Zilch, and serves as an investor for Sixfold Bioscience and QUEENSIDE GAMES LIMITED. As the co-founder and owner of THE RUN TO GROUP LTD, Welch specializes in organizing exclusive supercar adventures. Having established Persica Pharmaceuticals, Welch focuses on drug development targeting chronic lower back pain. Previous roles include director and co-owner of iSport GP2 Team and commercial director at KHP Consulting. Welch holds a background in communications management from CSS Stellar and completed education at Radley College.